[{"Assets_0_Q3_USD":315512000.0,"CommonStockSharesOutstanding_0_Q3_shares":93007844.0,"NetCashProvidedByUsedInOperatingActivities_1_Q3_USD":5638000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18679000.0,"NetIncomeLoss_1_Q3_USD":-11694000.0,"NetIncomeLoss_3_Q3_USD":-47928000.0,"StockholdersEquity_0_Q3_USD":114936000.0,"Ticker":"NVCR","CIK":"1645113","name":"NOVOCURE LTD","OfficialName":"NovoCure Limited Ordinary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8608333440.0","Country":"Jersey","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20181025"}]